Tenebrio molitor Larvae Inhibit Adipogenesis through AMPK and MAPKs Signaling in 3T3-L1 Adipocytes and Obesity in High-Fat Diet-Induced Obese Mice

Int J Mol Sci. 2017 Feb 28;18(3):518. doi: 10.3390/ijms18030518.

Abstract

Despite the increasing interest in insect-based bioactive products, the biological activities of these products are rarely studied adequately. Larvae of Tenebrio molitor, the yellow mealworm, have been eaten as a traditional food and provide many health benefits. Therefore, we hypothesized that T. molitor larvae might influence adipogenesis and obesity-related disorders. In the present study, we investigated the anti-adipogenic and antiobesity effects of T. molitor larvae in vitro and in vivo. The lipid accumulation and triglyceride content in mature adipocytes was reduced significantly (up to 90%) upon exposure to an ethanol extract of T. molitor larvae, without a reduction in cell viability. Exposure also resulted in key adipogenic and lipogenic transcription factors. Additionally, in adipogenic differentiation medium the extract induced phosphorylation of adenosine monophosphate (AMP)-activated protein kinase and mitogen-activated protein kinases. Daily oral administration of T. molitor larvae powder to obese mice fed high-fat diet attenuated body weight gain. We also found that the powder efficiently reduced hepatic steatosis as well as aspartate and alanine transaminase enzyme levels in mice fed a high-fat diet. Our results suggest that T. molitor larvae extract has an antiobesity effect when administered as a food supplement and has potential as a therapeutic agent for obesity.

Keywords: 3T3-L1; Tenebrio molitor larvae; adipogenesis; diet-induced obesity; hepatic steatosis.

MeSH terms

  • 3T3-L1 Cells
  • AMP-Activated Protein Kinases / metabolism*
  • Adipocytes / cytology
  • Adipocytes / drug effects
  • Adipocytes / metabolism*
  • Adipogenesis / drug effects*
  • Adipogenesis / genetics
  • Adipose Tissue / anatomy & histology
  • Adipose Tissue / drug effects
  • Animals
  • Anti-Obesity Agents / administration & dosage
  • Biological Products / administration & dosage*
  • Body Weight / drug effects
  • Cell Differentiation / drug effects
  • Diet, High-Fat
  • Dietary Supplements
  • Disease Models, Animal
  • Fatty Liver / drug therapy
  • Fatty Liver / etiology
  • Fatty Liver / metabolism
  • Gene Expression Regulation / drug effects
  • Larva*
  • Male
  • Mice
  • Mice, Obese
  • Mitogen-Activated Protein Kinases / metabolism*
  • Obesity / drug therapy
  • Obesity / etiology
  • Obesity / metabolism*
  • Phosphorylation
  • Signal Transduction / drug effects*
  • Tenebrio*
  • Transcription Factors / genetics
  • Transcription Factors / metabolism

Substances

  • Anti-Obesity Agents
  • Biological Products
  • Transcription Factors
  • Mitogen-Activated Protein Kinases
  • AMP-Activated Protein Kinases